Physician profile
Haider Alkhateeb
NPI 1891055794
$744.69
in general payments reported to CMS, 2019-2025
14 companies · $144 in 2025
The $144 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $137 · 2020: $112 · 2021: $78.67 · 2022: $85.90 · 2023: $23.41 · 2024: $164 · 2025: $144.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $332.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $331.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $174.70 | 2021-2025 | Cardiomems |
| United Therapeutics Corporation | $172.70 | 2019-2024 | |
| Actelion Pharmaceuticals US, INC. | $84.72 | 2020 | |
| Ekos Corporation | $77.32 | 2019 | |
| Heartflow, INC. | $39.72 | 2022 | |
| Boston Scientific Corporation | $39.62 | 2020-2025 | Watchman Flx |
| Alexion Pharmaceuticals, INC. | $30.66 | 2024 | Ultomiris |
| Cvrx, INC. | $23.41 | 2023 | Barostim Neo System |
| E.R. Squibb & Sons, L.L.C. | $22.82 | 2021 | |
| Philips North America LLC | $20.38 | 2024 | (5091) Amb Mon & Diag Und |
| W. L. Gore & Associates, INC. | $18.21 | 2021 | |
| Pfizer INC. | $15.51 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.99 | 2025 | Jardiance |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $10.93 | 2025 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Haider Alkhateeb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.